Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Announces Poster Presentation Featuring Novel Orexin Receptor 2 (OX2R) Agonist Discovery Pipeline at the 26th Conference of the European Sleep Research Society (Sleep Europe 2022)
- Data demonstrate potent efficacy of small-molecule OX2R agonists in a non-clinical model of narcolepsy type 1 (NT1) -- Company recognizes World Narcolepsy Day on September 22nd - BOSTON and LONDON
Source: finanznachrichten.de